Aktive Positionen von Yan Li
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Minimally Invasive Brain & Spine Institute | Direktor/Vorstandsmitglied | 01.07.2020 | - |
| Corporate Officer/Principal | 01.07.2020 | - | |
ExonanoRNA Therapeutics, Inc.
 ExonanoRNA Therapeutics, Inc. BiotechnologyHealth Technology ExonanoRNA Therapeutics, Inc. is an American company that specializes in RNA Nanotechnology, RNA DNA, and Exosome Research. The private company's focus is on developing innovative solutions in these areas. Yan Li has been the CEO of the company since 2021. | Direktor/Vorstandsmitglied | 01.08.2021 | - |
| Vorstandsvorsitzender | 01.08.2021 | - | |
| AIH LLC | Gründer | 01.12.2016 | - |
| Präsident | 01.12.2016 | - |
Karriereverlauf von Yan Li
Ehemalige bekannte Positionen von Yan Li
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EDOC ACQU | Direktor/Vorstandsmitglied | 12.10.2022 | 21.03.2024 |
| Independent Dir/Board Member | 12.10.2022 | 21.03.2024 |
Ausbildung von Yan Li
| Peking Union Medical College | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| China | 2 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sektoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Edoc Acquisition Corp.
 Edoc Acquisition Corp. Financial ConglomeratesFinance Edoc Acquisition Corp. is a blank check company, which engages in a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 20, 2020 and is headquartered in Victor, NY. | Finance |
| Minimally Invasive Brain & Spine Institute | |
ExonanoRNA Therapeutics, Inc.
ExonanoRNA Therapeutics, Inc. BiotechnologyHealth Technology ExonanoRNA Therapeutics, Inc. is an American company that specializes in RNA Nanotechnology, RNA DNA, and Exosome Research. The private company's focus is on developing innovative solutions in these areas. Yan Li has been the CEO of the company since 2021. | Health Technology |
| AIH LLC |
